Dr. Hüseyin Sancar Bozkurt

Dr. Hüseyin Sancar Bozkurt graduated from Trakya University Faculty of Medicine and completed his Internal Medicine residency at Çukurova University Faculty of Medicine. He then specialized in Gastroenterology at Adana Başkent University, further strengthening his expertise in this field.
He continued his academic career for six years as an Assistant Professor at Istanbul Maltepe University Gastroenterology Clinic, focusing extensively on gastrointestinal microbiota and conducting numerous significant scientific studies. He collaborated on microbiome research with the world-renowned gastroenterologist Prof. Dr. Eamonn Quigley.

Hüseyin Sancar Bozkurt

Dr. Bozkurt is known for his innovative approaches in gastroenterology and microbiota research. He is the inventor of the Endoscopic Bifidobacterium Administration/ Secondary Bacterial Transfer Therapy. His groundbreaking scientific studies earned him the distinction of being the first researcher to prove that microplastics can be biologically degraded by Bifidobacterium. His contributions to the field have been published in numerous national and international scientific articles and have been recognized with prestigious international awards. Additionally, he was invited to join Sigma Xi, one of the world's oldest and most esteemed scientific communities.
Dr. Hüseyin Sancar Bozkurt is the founder of Bioprobif, a pioneering biotechnology and probiotics company. As part of this initiative, he developed the probiotic product “Probif,” which contains Prebiotic XOS, Probiotic Bifidobacterium Infantis, and Postbiotic Alginate. He also led innovative research in producing biodegradable food packaging and bioplastic materials based on probiotic Bifidobacterium.

International Recognition & AGA Fellow (AGAF) Title
Due to his outstanding scientific contributions and academic achievements in gastroenterology, Dr. Hüseyin Sancar Bozkurt was honored with the prestigious "AGA Fellow" (AGAF) title by the American Gastroenterological Association (AGA), one of the world’s leading medical organizations.
This title is awarded exclusively to individuals who have made profound contributions to the field, distinguishing themselves through academic and clinical excellence. Dr. Bozkurt achieved the remarkable distinction of being only the second Turkish physician in the last 20 years and the sole recipient in the last 11 years. Additionally, he holds the record as the youngest Turkish gastroenterologist to receive this prestigious title.
Dr. Bozkurt’s recognition with this award is not only a personal milestone but also a testament to Turkey’s rising prominence in the medical world. Representing his country on an international stage, he continues to inspire young physicians through his academic contributions, groundbreaking research, and commitment to high-quality patient care.

Publications:

Hazan S, Stollman N, Bozkurt HS, et al Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity BMJ Open Gastroenterology 2022;9:e000871. doi: 10.1136/bmjgast-2022-000871

 

Hüseyin Sancar Bozkurt, Hülya Civelek Yörüklü; Kutsal Bozkurt; Cenk Denktaş; Altan Bozdoğan; Orhan Özdemir; Bestami Özkaya; Biodegradation of microplastic by probiotic bifidobacterium International Journal of Global Warming (IJGW), Vol. 26, No. 4, 2022

 

Denktaş, C., Baysoy, D. Y., Bozdoğan, A., Bozkurt, H. S., Bozkurt, K., Özdemir, O., & Yilmaz, M. (2022). Development and characterization of sodium alginate/bifidobacterium probiotic biohybrid material used in tissue engineering. Journal of Applied Polymer Science, 139(18), 52086. https://doi.org/10.1002/app.52086

 

Bozkurt, H. S., Bilen, Ö. (2021). Oral booster probiotic bifidobacteria in SARS-COV-2 patients. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177_20587384211059677

 

Bozkurt, H. S.,Bilen, Ö. (2021). Gastrointestinal symptoms in COVID-19 could be associated with severe lung involvement and increased readmission rates. European Journal of Inflammation.  https://doi.org/10.1177_20587392211048259

 

Bozkurt HS, Quigley EM. The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis. International Journal of Immunopathology and Pharmacology. January 2020. doi:10.1177/2058738420961304

 

Bozkurt HS, Kara B. A new treatment for ulcerative colitis: Intracolonic Bifidobacterium and xyloglucan application. European Journal of Inflammation. January 2020. doi:10.1177/2058739220942626

 

Bozkurt, C. Denktas, O. Ozdemir, A. Altındal, Z. Avdan, H. S. Bozkurt. Charge Transport in Bifidobacterium animalis subsp.lactis BB-12 under Various Atmospheres.OJAPPS 2019. DOI: 10.4236/ojapps.2019.96040.

 

Hüseyin Sancar Bozkurt, Eamonn M. M. Quigley.Bifidobacteria and Mucosal-Associated Invariant T (MAIT) Cells: A New Approach to Colorectal Cancer Prevention?. Gastrointest. Disord. 2019, 1(2), 266-272; https://doi.org/10.3390/gidisord1020022

 

Hüseyin Sancar Bozkurt,Banu Kara.Combination of oral vancomycin and intra-colonic vancomycin:

Successful treatment of complicated pseudomembranous colitis in a child patient.SAGE 2019;7: doi: 10.1177/2050313X19838442

 

Bozkurt, H.S., E. MM Quigley, B. Kara, 2019. Bifidobacterium animalis subspecies lactis engineered to produce mycosporin-like amino acids in colorectal cancer prevention. SOM 2019; Vol. 7: 1–5

 

Hüseyin Sancar Bozkurt,  Banu Kara. Can Fortified Bifidobacterium with Mycosporin-like Amino Acid be a New Insight for Neurological Diseases’ Treatment?. Autism-Open Access 2017, 7:5.DOI: 10.4172/2165-7890.1000219

Bozkurt HS, Kara B. Bifidobacterium and Mycosporin-like Amino Acid Cooperation: A New Era for Intestinal Diseases Treatment?. J Gastric Disord Ther (2017) 3(2)

Awards:
  1. American Gastroenterological Association “Clinician Advice Award 2017”

https://www.mdedge.com/gihepnews/article/157083/register-early-aga-postgraduate-course

  1. American Gastroenterological Association “2017 Top Contributor Achievement”

https://www.mdedge.com/gihepnews/article/157088/endoscopy/2017-gi-thought-leaders

  1. American Gastroenterological Association Basic Sciences Award (2018)
    BIFIDOBACTERIUM ANIMALIS SUBSPECIES LACTIS ENGINEERED TO PRODUCE  MYCOSPORIN – LIKE  AMINO ACIDS IN COLORECTAL CANCER PREVENTION. UEG Week 2018 October 20-24, 2018, Vienna – Austria
  1. “Microbiome from Mother to Child” Symposia America Scholarship Award, Harnessing the Microbiome for Disease Prevention and Therapy joint with MEETING CHANGE TO VIRTUA: The Microbiome: From  Mother to Child Organizer(s): Eric G. Pamer, Laurie E. Comstock and Alan Walker Date: January 17 – 21, 2021, Scholarship award.
  2. COVID19 da “Single Species Probiotic Bacteria Therapy” at COVID19, Best study and best presentation award, Korean Gastroenterology Week, KGFID award in KDDW2021
  3. Sigma Bilimsel Topluluk tam üyelik ödülü. Full Member of Sigma Xi, The Scientific Research Honor Society , 2024
  4. American Gastroenterology Specialty Award, AGA Fellow, 2025
Fields of Interest:
  • Endoscopy
  • Colonoscopy
  • Dysbiosis (Intestinal Flora Disorder)Inflammatory
  • Intestinal Diseases (Ulcerative Colitis, Crohn’s, Celiac)
  • İBS
  • SİBO
  • Permeable Intestine
  • Gut Related Autoimmune Disorders (Hashimoto’s, DM, Allergy, Urticaria, Eczema, Asthma, Pancreatic disorders)
  • Functional Diarrhea
  • Functional Constipation
  • Intestinal Diverticula
  • Probiotics